PAVmed (PAVM)
(Delayed Data from NSDQ)
$0.41 USD
-0.05 (-11.68%)
Updated Aug 7, 2025 03:59 PM ET
After-Market: $0.40 -0.01 (-2.44%) 4:32 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, PAVmed Inc. has a market cap of $7.93M, which represents its share price of $0.46 multiplied by its outstanding shares number of 17.09M. As a small-cap company, PAVM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PAVM 0.41 -0.05(-11.68%)
Will PAVM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PAVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PAVM
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know
Lucid Inks New Partnership With VITALExam: Stock to Gain?
PAVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates
Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates
Other News for PAVM
PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 | PAVM Stock News
PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule | ...
PAVmed gets 180-day extension to regain Nasdaq listing compliance
Lucid says meeting scheduled to determine Medicare coverage for cancer test
PAVmed Inc. Completes First in Human Trial of PortIO Intraosseous Infusion System